Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Engel

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Mabs|September 30, 2015
The European antibody network's practical guide to finding and validating suitable antibodies for researchGiovanna Roncador, Pablo Engel, Lorena Maestre, et al.
Blood|July 16, 2005
CD molecules 2005: human cell differentiation moleculesHeddy Zola, Bernadette Swart, Ian Nicholson, et al.
Cancer Immunology Research|June 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is LimitedLuis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, et al.
Frontiers in Immunology|October 10, 2022
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel diseaseSergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, et al.
Ebiomedicine|January 15, 2022
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersGemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
Microbiology Spectrum|January 9, 2023
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care WorkersRuth Aguilar, Xue Li, Claudia S Crowell, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Journal of Hematology & Oncology|July 2, 2025
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemiaNéstor Tirado, Klaudyna Fidyt, María José Mansilla, et al.
Science Immunology|May 30, 2025
Human LY9 governs CD4<sup>+</sup> T cell IFN-γ immunity to <i>Mycobacterium tuberculosis</i>Masato Ogishi, Julia Puchan, Rui Yang, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Mabs|September 30, 2015
The European antibody network's practical guide to finding and validating suitable antibodies for researchGiovanna Roncador, Pablo Engel, Lorena Maestre, et al.
Blood|July 16, 2005
CD molecules 2005: human cell differentiation moleculesHeddy Zola, Bernadette Swart, Ian Nicholson, et al.
Cancer Immunology Research|June 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is LimitedLuis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, et al.
Frontiers in Immunology|October 10, 2022
Experimental and genetic evidence for the impact of <i>CD5</i> and <i>CD6</i> expression and variation in inflammatory bowel diseaseSergi Casadó-Llombart, María Velasco-de Andrés, Cristina Català, et al.
Ebiomedicine|January 15, 2022
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workersGemma Moncunill, Ruth Aguilar, Marta Ribes, et al.
Microbiology Spectrum|January 9, 2023
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care WorkersRuth Aguilar, Xue Li, Claudia S Crowell, et al.
Molecular Therapy. Methods & Clinical Development|January 10, 2019
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic InstitutionsMaria Castella, Anna Boronat, Raquel Martín-Ibáñez, et al.
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Journal of Hematology & Oncology|July 2, 2025
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemiaNéstor Tirado, Klaudyna Fidyt, María José Mansilla, et al.
Science Immunology|May 30, 2025
Human LY9 governs CD4<sup>+</sup> T cell IFN-γ immunity to <i>Mycobacterium tuberculosis</i>Masato Ogishi, Julia Puchan, Rui Yang, et al.
Pageof 11